Antisense oligonucleotide modulating cyclin e gene expression and therapeutic uses thereof
CA 2377273 A1 · Owner: Levesque, Luc · Inventors: Levesque, Luc
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to antisense oligonucleotides directed to the human cyclin E gene for inhibiting its expression and to a method for , inhibiting cellular proliferation. The antisense oligonucleotides of the present invention have been designed from the 5' and 3'-untranslated region of the cyclin E gene for inhibiting the expression of the cylcing E gene. These antisense oligonucleotides can be used for research purposes diagnostics and , treatment of disease. Methods for specifically modulating cyclin E expression in cells and tissues using the antisense oligonucleotides are disclosed. Methods for diagnosis, detection and treatment of pathologies involving cyclin E gene …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 19, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 19, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 19, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.